ARBUS LOCKLEAR: Open Payments
NPI 1982697355 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,317 in 119 payments from 19 companies in 2025. Trend: 2023 $2,090 · 2024 $2,329 · 2025 $2,317
Food & beverage: $2,297Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $436 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $389 |
| Amgen Inc. | 29 | $355 |
| Novo Nordisk Inc | 11 | $261 |
| Lilly USA, LLC | 8 | $156 |
| Paratek Pharmaceuticals, Inc. | 7 | $125 |
| Corcept Therapeutics | 6 | $101 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| ABBVIE INC. | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
Products named: Kerendia, BREZTRI, KRYSTEXXA, Ozempic, FARXIGA, MOUNJARO, OTEZLA, NUZYRA.
Industry payments across NC — which companies pay providers there.
